Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation
Scientific studies have established associations between chemical hair relaxers containing endocrine-disrupting chemicals (EDCs) like phthalates and formaldehyde-releasing agents and increased risks of reproductive cancers. Epidemiological research indicates that frequent and long-term use of these products correlates with higher incidences of uterine, ovarian, and cervical cancers, especially among Black women who are disproportionately exposed. The biological mechanism involves EDCs mimicking estrogen, disrupting hormonal regulation, and potentially leading to tumor development. Regulatory agencies like the FDA have identified formaldehyde-releasing agents as carcinogenic, further supporting the causation theory.
11,877
Pending actions
16,059
Total actions filed
Active
Status
02/06/2023
Established
Who qualifies
Plaintiffs must demonstrate long-term, regular exposure to chemical hair relaxers, typically over months or years, with diagnoses of specific reproductive cancers occurring within a legally relevant timeframe prior to filing. The injuries include uterine, ovarian, and cervical cancers, among others, linked to exposure to endocrine-disrupting chemicals such as phthalates and formaldehyde-releasing agents present in the products. The exposure must be significant enough to establish causation, often supported by medical records and exposure history.
Products involved
- L'Oréal hair relaxers
- Revlon hair relaxers
- Strength of Nature relaxers
- Namaste Laboratories relaxers
Alleged injuries
- uterine cancer
- ovarian cancer
- cervical cancer
- reproductive health disorders
This page is generated from the official JPML pending-MDL report and public court records, refreshed monthly. It is provided for attorney reference and is not legal advice.
